Ryuichi Mizuno
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 5%
- Surgery top 10%
- Co-authors
- Mototsugu OyaShuji MikamiTakeo KosakaMasaru MuraiEiji KikuchiYasunori OkadaKen MarumoAkira Miyajima
- Topics
- Renal cell carcinoma treatment (65 papers)Bladder and Urothelial Cancer Treatments (51 papers)Prostate Cancer Diagnosis and Treatment (36 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaThe EMBO Journal
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Ryuichi Mizuno
191 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 104
- Pulmonary and Respiratory Medicine 1.2k
- Molecular Biology 1.1k
- Oncology 926
- Cancer Research 526
- Surgery 509
Countries citing papers authored by Ryuichi Mizuno
This map shows the geographic impact of Ryuichi Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuichi Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuichi Mizuno more than expected).
Fields of papers citing papers by Ryuichi Mizuno
This network shows the impact of papers produced by Ryuichi Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuichi Mizuno. The network helps show where Ryuichi Mizuno may publish in the future.
Co-authorship network of co-authors of Ryuichi Mizuno
This figure shows the co-authorship network connecting the top 25 collaborators of Ryuichi Mizuno. A scholar is included among the top collaborators of Ryuichi Mizuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuichi Mizuno. Ryuichi Mizuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 57 | |
| 11 | 9 | |
| 12 | 20 | |
| 13 | 20 | |
| 14 | 上部尿路尿路上皮癌における赤血球蛋白質バンド4.1like5発現の予後的意義【Powered by NICT】 | 1 |
| 15 | 17 | |
| 16 | 25 | |
| 17 | 32 | |
| 18 | 9 | |
| 19 | 24 | |
| 20 | 103 |
About Ryuichi Mizuno
Ryuichi Mizuno is a scholar working on Urology, Pulmonary and Respiratory Medicine and Oncology, having authored 205 papers that have together received 2.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (65 papers), Bladder and Urothelial Cancer Treatments (51 papers) and Prostate Cancer Diagnosis and Treatment (36 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Cancer Research (526 citations) and Oncology (926 citations). Ryuichi Mizuno has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Mototsugu Oya, Shuji Mikami, Takeo Kosaka, Masaru Murai, Eiji Kikuchi, Yasunori Okada, Ken Marumo, Akira Miyajima, Toshiaki Shinojima and Nobuyuki Tanaka. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.